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Abstract.  Protein kinase C  (PKC) plays a  central role 
in the control of proliferation and differentiation of a 
wide range of cell types by mediating the signal trans- 
duction response to hormones and growth factors. 
Upon activation by diacylglycerol, PKC translocates to 
different subcellular sites where it phosphorylates 
numerous proteins, most of which are unidentified. 
We used the yeast two-hybrid system to identify pro- 
teins that interact with activated PKCot. Using the 
catalytic region of PKC fused to the DNA binding do- 
main of yeast GAL4 as "bait" to screen a  mouse 
T  cell cDNA library in which cDNA was fused to the 
GAL4 activation domain, we cloned several novel pro- 
teins that interact with C-kinase (PICKs).  One of these 
proteins, designated PICK1, interacts specifically with 
the catalytic domain of PKC and is an efficient sub- 
strate for phosphorylation by PKC in vitro and in 
vivo. PICK1 is localized to the perinuclear region and 
is phosphorylated in response to PKC activation. 
PICK1 and other PICKs may play important roles in 
mediating the actions of PKC. 
p 
ROTEIN kinase C  (PKC) ~ is a calcium and phospho- 
lipid-dependent serine/threonine protein kinase that 
is rapidly activated in response to a variety of hor- 
mones, mitogens, and neurotransmitters (Nishizuka, 1992). 
At least nine isoforms of PKC have been identified, most of 
which share a common structural organization in which an 
amino-terminal regulatory domain is  separated  from the 
carboxyl-terminal catalytic domain by a  central hinge re- 
gion. In resting cells, a pseudosubstrate sequence near the 
amino terminus is thought to occupy the active site, thereby 
maintaining the  enzyme in  an  inactive state  (House and 
Kemp,  1987).  Upon stimulation of cells with activators of 
phosphatidylinositol turnover,  diacylglycerol and calcium 
are released intracellularly and bind to the regulatory do- 
main leading to allosteric activation of the enzyme. 
Activation of PKC  is  accompanied by its translocation 
from the cytoplasm to the plasma membrane and other sub- 
cellular sites,  including the Golgi apparatus  (Saito et al., 
1989),  the perinuclear region (Chen et al., 1987; Halsey et 
al., 1987; Thomas et al., 1988; Fields et al., 1989; Mochly- 
Rosen et al., 1990; James and Olson, 1992), and the nucleus 
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(Kraft and Anderson,  1983;  Jaken et al.,  1989;  Mochly- 
Rosen, 1990; Saraste et al., 1990). Certain isoforms of PKC 
have also been shown to translocate to the nuclear envelope 
upon activation, where they may regulate nuclear envelope 
breakdown or changes in gene expression that accompany a 
mitogenic response (Cambier et al.,  1987; Huange et al., 
1988; Thomas et al.,  1988;  Leach et al., 1989; Masmoudi 
et al., 1989; Fields et al.,  1989, 1990;  Rogue et al.,  1990; 
Divecha et al., 1991; Hocevar and Fields, 1991; Block et al., 
1992; Eldar et al., 1992; James and Olson, 1992; Matter et 
al.,  1993). 
Mutagenesis of PKCot has revealed regions in the hinge 
and catalytic domain that mediate translocation to the nu- 
cleus (Eldar et al., 1992; James and Olson, 1992). These do- 
mains appear to be masked in the inactive enzyme, but they 
become  exposed  upon  enzyme activation in  response  to 
phorbol esters. Deletion of the regulatory domain of PKCa 
releases the enzyme from its dependence on cellular cofac- 
tors for activity and renders it constitutively active (Kaibuchi 
et al.,  1989;  Muramatsu et al.,  1989;  James and Olson, 
1992). In some cell types, such deletion mutants are translo- 
cated to the nucleus, presumably because of the unmasking 
of one or more nuclear targeting sequences (Eldar et al., 
1992; James and Olson, 1992). How PKC becomes targeted 
to the nucleus or the plasma membrane remains unknown, 
but the specificity in targeting suggests that it may involve 
specific proteins at these subcellular sites that recognize and 
bind  PKC.  In  this  regard,  Mochly-Rosen and coworkers 
(Mochly-Rosen et al.,  1991a, b; Ron et al., 1994) have de- 
scribed "receptors" for PKC, termed RACKS, that bind acti- 
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ent  subcellular  sites.  Intracellular  PKC-binding  proteins 
have also been identified by Jaken and coworkers (Chapline 
et al.,  1993). 
Despite a great deal of information on the structure,  func- 
tion, and regulation of PKC, relatively little is known of the 
proteins with which PKC interacts in vivo to elicit its diverse 
cellular responses. At least three types of proteins can be en- 
visioned that would interact with PKC in vivo; those that are 
substrates  for the  enzyme,  those  that  are  inhibitors,  and 
those that direct the enzyme to different subcellular sites by 
serving as chaperons or intraceliular receptors. In an attempt 
to identify cellular proteins that may interact with activated 
PKC and participate  in the PKC signal transduction pathway, 
we used the yeast two-hybrid system to isolate eDNA clones 
encoding proteins that interact with C kinase (PICKs).  Here 
we describe one such protein, PICK1, which is localized pri- 
marily to the perinuclear region where it serves as a sub- 
strate for PKC. PICK1 and other PICKS are likely to partici- 
pate in transduction  of PKC  signals in vivo. 
Materials and Methods 
Construction of GAL4 (DB)-PKC Chimeras and 
Library Screening 
The GAL4 (DB)-PKC'/fusion plasmid was constructed from a deletion mu- 
tant of bovine PKCc~ (Coussens et al., 1986), termed PKC'/(James and Ol- 
son,  1992),  which encodes amino acids  302-672.  PKC7  in pCDM8* 
(James and Olson, 1992) was digested with BanI, the 1.1-kb fragment en- 
coding PKC7 was isolated,  and the ends were filled with Klenow polymer- 
ase and deoxynucleotide  triphosphates followed by digestion with BamHI. 
The fragment was then inserted into the Sinai and BamI-II sites in pAS-1 
(Durfee et aL,  1993),  which encodes the DNA binding domain (DB) of 
yeast GALA encompassed by amino acids  1-147. The GAL4(DB)-PKC 
regulatory domain plasmid (GAL4(DB)-PKC-R)  was constructed by digest- 
ing PKCc~ in pCDM8* with NCOI, gel purifying the 1.2-kb fragment, and 
ligating it to pAS-1 linearized with NcoI. The GAL4(DB)-E12  fusion plas- 
mid was constructed as described (Staudinger et al., 1993). The GALA(TA) 
eDNA fusion library contains cDNA fused to the GAL4 transcription acti- 
vation (TA) domain and was  constructed from mouse T  cell poly(A) + 
mRNA and was converted to plasmid form using k-act as described (Durfee 
et al., 1993). GAIA(DB)-PKCa was created by cloning the complete coding 
region of bovine PKCct in frame to GALb147 using an NcoI site at the initi- 
ating methionine codon in PKC. 
Yeast strain Y153 (MATa, gal4, galS0, his3, trpl-901, ade2-101, ura3-52, 
leu2-3, -112, URA3::GAL~IacZ, LYS2::GAL~HIS3) was used. Transfor- 
mation was by the method of Schiesfl and Gietz, (1989). A typical transfor- 
marion yielded  3  ×  104 transformants//~g of plasmid DNA. Briefly, cells 
were grown in one liter of YPD or the appropriate selective minimal media 
to an ODeoo of 0.5-0.8.  The cells were harvested by centrifugation and 
re.suspended in 250 ml of water and centrifuged again. The washed pellet 
was resnspended in 100 ml of LISORB (100 Mm LiOAc, 10 mM Tris, pH 
8.0,  1 mM EDTA,  1 M Sorbitol) and shaken gently at 30°C for 30 rain. 
Cells were then pelleted as before and resnspended in 2.0 ml LISORB in 
a 50-ml conical tube and incubated on ice. Denatured salmon sperm carrier 
DNA (800/A of a 10 mg/mi solution) was mixed with 1.6 ml of LISORB 
and the mixture was allowed to cool to room temperature.  80/~g of library 
plasmid DNA was added to the cooled carrier DNA-LISORB mixture and 
mixed  thoroughly.  This mixture was  added to the chilled cells,  mixed 
briefly, and incubated without shaking for 30 to 60 rain at 30°C. After in- 
cubating, 20ml of LIPEG (40% PEG 3350, 1.0 M LiOAc, 1x TE, pH 8.0) 
was added and mixed by inversion. This suspension was incubated for 30 
rain at 30°C,  after which it was  placed in a 42°C  water hath and heat 
shocked for 10 rain. The cell suspension was then added to 0.51 of synthetic 
complete (SC) media lacking the amino acids tryptophan, lenoine, and histi- 
dine (6.7 g/L yeast extract minus amino acids,  20 g/1 dextrose,  0.87 g/l 
amino acid powder, +  20 g ngar/1) and shaken at 250 rpm at 30°C for 3 h. 
The cells were harvested as before and resnspended in 10 ml of SC media 
lacking tryptopban, leucine, and histidine. 30 300-/~1 aliquots were plated 
on 15-cm plates containing SC-try, leu, and his, +  25 mM 3-amino-l,2,4- 
triazole (A-8056; Sigma Chem. Co., St.  Louis,  MO) and grown for 10 d 
before assaying  for ~-galactosidase  activity. 
Expression Vectors  and Yeast  Screen 
Yeast harboring both GAIA(DB) and GAL4(TA) fusion proteins were moni- 
tored for/~-galactosidase activity using plate and liquid assay  methods. 
Yeast transformants were transferred to nitrocellulose  membrane, permea- 
bilized in liquid nitrogen, and placed on Whatman no. 3 filter paper that 
had been soaked in Z-buffer (60 mM Na2HPO,t, 40 mM NaH2PO4, 10 mM 
MgCl2, 50 mM ~-mercaptoethanol) containing 1.0 mg/ml X-gal. Positive 
colonies appeared in 10 rain to 10 h. Liquid cultures of 2.5 ml were grown 
in the appropriate selective media to an OD~o of 1.0 to 1.2 for quantitative 
ONPG assays as described (Guarente,  1993).  To rescue GAL(TA) fusion 
plasmids, total yeast DNA was isolated by the method of Hoffman and Win- 
ston (1987), except that the DNA was precipitated with one half volume of 
7.5 M ammonium acetate and one volume of isopropanol.  The pellet was 
washed twice in 70% ethanol and resnspended in 20 ttl of sterile distilled 
water and used to electroporate E. coli DH5-~ cells as recommended in the 
Bio-Rad users guide for the Gene-Pulser. 
Construction of GST-PICKI, pRSET-PICK1, and 
PECEFLAG-PICK1 Fusion Protein 
GAL4(TA)-PICKI  was digested with BgllI and the resulting 1.7-kb cDNA 
insert was gel purified and used to create all of the following plasmids.  To 
obtain the GST-PICK1 fusion, the cDNA was ligated to pGEX-3X (27-4803- 
01; Pharmacia LKB Nuclear, Gaithersburg,  MD) which had been finearized 
with BamI-II. For in vitro transcription and translation, the eDNA was 
ligated to pRSET A (V350-20; Invitrogen,  San Diego, CA) which bad been 
digested with BglII.  TO obtain an expression vector for transfections,  the 
eDNA was ligated  to PECE-FLAG (Ellis et al.,  1986) which had been 
digested  with BglII.  All plasmids  were  sequenced  to ascertain reading 
frame and orientation using Sequenase 2.0 according to the manufacturer's 
specifications  (Un. States Biochem. Corp., Cleveland,  OH). 
In Vitro Transcription and Translation and Expression 
of  Bacterial Fusion Proteins 
In vitro translation of PICK1 was performed using the TNT rabbit reticulo- 
cyte lysate kit (Promega Corp.) according to manufacturer's  instructions. 
The myogenin and MEF2C cDNAs used as negative controls have been de- 
scribed (Edmondson and Olson, 1989; Martin et al.,  1993). 
The GST-PICKI  fusion protein was  isolated from DH5ct cells trans- 
formed with the GST-PICKI  plasmid. The GST-myo fusion protein con- 
rained amino acids 33-224 of mouse myogenin,  cloned in frame to GST 
(Chakraborty et al.,  1991). Following induction of the fusion protein with 
0.5 mM IP'rG (0.24 g/l) for 4 to 6 h, the GST-PICK1 fusion protein was 
purified on glutathione agarose beads (Pharmacia), as described (Chakra- 
borty et al.,  1991). 
Binding of  GST-PICKI and In Vitro Translated  PKC7 
To test for interactions between PICK1 and PKC7 or PCKcx in vitro,  '~15 
~,g GST-PICKI  was incubated with 20,000  cpm of [35S]-labeled in vitro 
translation products  in 300/~1 of incubation buffer (50 mM KCI, 40 mM 
Hepes pH 7.5, 5 mM mercaptoethanol, 0.1% Tween-20, 0.5%  nonfat dry 
milk). The effects of PKC cofactors  on binding of PKCc~ to GST-PICK1 
were determined in the presence of 1 mM calcium and 80/~g/ml PS. The 
slurry was allowed to rock at 4°C for 30 rain. The beads were then washed 
five times in 1 ml of NETN and five times in 1 ml of incubation buffer con- 
raining 100 mM KC1. After washing and removing the final supernatant, 
the samples were resnspended in 50/~1 of 2× SDS sample buffer. The sam- 
ples were boiled for 10 rain and resolved on 10% SDS-polyacrylamide gels. 
The gels  were  dried and autoradiography  was  performed  overnight  at 
-80°C. 
In Vitro Phosphorylation of  GST-PICK1 
For in vitro pbosphorylation, 5/~g of GST-PICKI was brought to a final vol- 
ume of 40/zl with water. Ten/tl of solution A (120 mM Tris,  pH 7.5, 60 
mM MgC12, 6 mM CaCi2) was added, followed by 5/tl of phosphatidylser- 
ine (1  rng/ml)  and 2.0 /zl of PKCcx (Promega).  After mixing,  1 /~1 of 
•  y-[32p]ATP (10 mCi/ml) was added and the reaction was incubated for 5 
rain at 30°C. One ill of 1 mM unlabeled ATP was then added and the incuba- 
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SDS-sample buffer, boiled for 10 min, and then resolved by SDS-PAGE. 
Gels were dried and autoradiography was performed for 1 to 5 h at room 
temperature. 
Transfection and Immunofluorescence of  PICK1 and 
COS1 Cells 
COSI cells were grown to 50-80% confluency in DMEM containing 10% 
FBS and transfected by calcium phosphate precipitation  using 20/~g of 
PECE FLAG-PICKI expression vector. Cells were refed with fresh medium 
18 h after transfection and were analyzed for exogenous PICK1 expression 
2 d later. 
For immunostaining, cell monolayers were washed with PBS and fixed 
for 5 rain at room temperature in ice cold absolute alcohol. The ceils were 
then rinsed three times quickly with PBS followed by incubation for 30 rain 
at room temperature in 3 % BSA, 0.1% NP-40 in PBS. The primary antibody 
(anti-FLAG M2 MAb, Kodak) was added at a 1:1,000 dilution and incuba- 
tion was continued for an additional 30 min at 37°C. Two quick washes 
using 0.1% NP-40 in PBS were performed followed by one wash for 15 rain 
with gentle agitation at room temperature. The secondary antibody (FITC- 
labeled horse anti-mouse, BA2000; Vector Labs. Inc.,  Burlingame, CA) 
was diluted in 3% BSA, 0.1% NP-40 in PBS as per manufacturer's instruc- 
tions and incubated at 37°C in the dark for 30 min. The cells were washed 
as before and visualized using immunofluorescence microscopy. 
In Vivo Labeling and Immunoprecipitation 
For 32p-labeling, transfected  cells  were  transferred  into  phosphate-free 
medium (Signm) two days after transfection. The cells were then incubated 
for 8 h before adding [32p]ortho-phosphate (ICN Biomedicals Inc., Costa 
Mesa, CA) at  1 mCi/ml for an additional 4 h. After labeling, cells were 
lysed in RIPA buffer (50 mM Tris, pH 8.0, 0.1% SDS, 1% NP-40, 0.5% So- 
dium  Deoxycholate,  150  mM  NaCI,  5  mM  EDTA, 30  mM  Na 
pyrophosphate, 10 mM NaF, 1 mM PMSF, 1% Apoprotinin) and the lysate 
was homogenized by aspiration through a 26-gange needle attached to a 
l-ml  syringe  10  times  to  reduce  viscosity.  The  homogenate  was  the 
microfuged for 5 rain at 4°C. The anti-FLAG antibody M2 was added to 
the supernatant at 2/~g/ml and incubated on ice for 1 h. 20/zl of protein 
A-agarose (Oncogene Science, Inc.) beads were added and incubated for an 
additional 30 rain on ice. The beads were collected and washed three times 
in RIPA buffer containing 500 mM NaCI, followed by a final wash in PBS. 
The pellet was then resuspended in SDS sample buffer and heated to 95°C 
for three min. The samples were spun in a microfuge for 1 rain at 4°C and 
the supernatant was resolved on 10% SDS-polyacrylamide gels. The gels 
were dried and autoradiography was performed overnight at  -80°C. 
DNA Sequencing and Sequence Analysis 
DNA sequencing of PICK1 cDNAs was performed on both strands using 
an Applied Biosystems automated sequencer using oligonuclcotide primers 
that annealed every 250 bp along the cDNAs. DNA sequences were ana- 
lyzed using the GCG Sequence Analysis Software Package. 
Results 
Screening for PKC-Binding Proteins Using the 
Two-hybrid System 
To search for cDNA clones encoding proteins that interact 
with PKC, we used the two-hybrid system for detection of 
protein-protein interactions in yeast (Fields and Song, 1989; 
Chien et al.,  1991;  Durfee et al.,  1993).  The yeast strain 
used for the screen harbored integrated lacZ and HIS3 genes 
under control of the GAIA upstream  activating sequence 
(UAS).  These marker genes are transcriptionally silent in 
this strain and are dependent on binding of a transactivator 
to the UAS for expression. As "bait  ~, we created a plasmid 
called  GAL4(DB)-PKC7,  which  contained  amino  acids 
302-672 of bovine PKCc~ fused in-frame to the DNA bind- 
ing domain of yeast GAL4, encoded by amino acids  1-147 
Figure 1.  Structure of GAL4(DB)-PKC7. The structure of bovine 
PKCc~ is  depicted at the top.  Conserved  (C)  and variable (V) 
regions  are  indicated  in  light  and  dark  grey, respectively. 
GAL4(DB)-PKC7 contains amino acids 302-672 of bovine PKCc~ 
fused to the DNA-binding domain of GAL4. This contains part of 
the V3 hinge region, which starts at amino acid 290. Details of the 
expression plasmid are in the text. 
(Fig. 1). This region of PKCo~, which corresponds to a PKC 
deletion mutant previously termed PKC7,  contains part of 
the  V3  hinge  region  and  the  complete catalytic domain. 
PKC7 shows constitutive kinase activity and becomes local- 
ized to the nucleus of transfected COS cells (James and Ol- 
son,  1992). 
Because GAIA(DB)-PKC7 lacks transcriptional activity 
on  its  own (Table  I)  and  is  therefore  undetectable  by  selection, 
we confirmed that  it  was expressed in  yeast  by Western blot 
analysis  of  extracts  from yeast  transformed with the  GAIA- 
(DB)-PKC7  expression  vector.  Antibody against  GALl447 
detected a protein  of 57 kD in cells  transformed with the 
GAL(DB)-PKC7  plasmid, but not in untransformed  yeast 
(data  not shown). This agrees  with the  predicted  size  of  the 
GALA(DB)-PKC7  fusion  protein. 
To  identify  eDNA  clones  encoding proteins  that  interacted 
with  PKC,  we  transformed  the above  yeast strain  with 
GAL(DB)-PKC7  and  a  mouse T cell  eDNA  library  in  which 
eDNA  was fused to the GAL4  transcription  activation  do- 
main. Screening of  3 x  I0  ~  independent transformants  for 
activation  of  the  lacZ  and  HIS3  markers yielded 12  colonies 
that  stained  intensely  for  B-galactosidase  activity  within  30 
min. Many  colonies showed lacZ activity  following over- 
night incubation. However,  we  focused  only  on  the  12 
strongly  positive  clones. 
To determine  whether activation  of the UAS-dependent 
marker  genes by  the  above  clones  reflected  a  specific  interac- 
tion of the encoded  proteins with  the  PKC  portion of 
GAL4(DB)-PKC7,  each  cDNA  clone  was  rescued  from  yeast 
and was retransformed into  the same yeast  strain  in  the ab- 
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by GAL4 Chimeras 
Bait  Prey  B-Gal activity 
None  None  <0.01 
GAL4(DB)-PKC7  None  <0.01 
GAL4(DB)-PKC-R  None  <0.01 
GAL4(DB)-PKCa  None  <0.01 
GAL4(DB)-E12  None  <0.01 
GAL4(DB)-PKC7  PICK  1  50.20 
GAL4(DB)-PKC-R  PICK1  <0.01 
GAL4(DB)-PKCc~  PICKI  <0.01 
GAIA(DB)-E  12  PICK1  <0.01 
GAL4(DB)-PKC7  PICK2  75.70 
GAL4(DB)-PKC-R  PICK2  78.30 
GAL4(DB)-PKCct  PICK2  <0.01 
GAL4(DB)-E12  PICK2  <0.01 
GAL4(DB)-PKC7  PICK3  100.00 
GAL4(DB)-PKC-R  PICK3  <0.01 
GAL4(DB)-PKCc~  PICK3  <0.01 
GAL4(DB)-E12  PICK3  <0.01 
GAL4(DB)-PKC7  PICK4  83.60 
GAL4(DB)-PKC-R  PICK4  <0.01 
GAL4(DB)-PKCc~  PICK4  <0.01 
GAL4(DB)-E  12  PICK4  <0.01 
GAL4(DB)-PKC7  PICK5  97.20 
GAL4(DB)-PKC-R  PICK5  <0.01 
GALAt(DB)-PKCa  PICK5  <0.01 
GAL4(DB)-EI2  PICK5  <0.01 
Yeast transformed  with the indicated  expression  plasmids were grown  to mid- 
log phase in SC lacking the appropriate  amino acid(s). Extracts  were  prepared 
and assayed for B-galactosidase activity as described in the text. /~-galac- 
tosidase activity  is expressed  as percent  of activity  in extracts  with GAL4(DB)- 
PKC7 + GAL4(AD)-PICK3. 
sence of GAL(DB)-PKC7. We also expressed each of the ac- 
tivating plasmids with an expression plasmid in which the 
GAL4 DNA binding domain was fused to a nonspecific pro- 
tein; in this case we used the transcription factor El2, which 
would not be expected to interact with proteins that bind to 
PKC. 7 of the 12 clones were able to activate expression of 
the marker genes in the absence of  GAL(DB)-PKC7 or in the 
presence of GAL4(DB)-E12,  suggesting  that the proteins 
they  encoded  interacted  directly  with  the  GAL4  DNA- 
binding domain or with the target genes themselves. The re- 
maining five clones.were all specific in that they activated 
lacZ expression only in the presence of GAL4(DB)-PKC7. 
We named the proteins encoded by these cDNAs PICKS. An 
indication of the relative strengths of the interactions be- 
tween the above PICKs and PKC7 was obtained by quantitat- 
ing/3-gal activities in extracts of yeast harboring the DNA 
binding and activating plasmids. The five PICKs appeared to 
interact with GAL4(DB)-PKC7 similarly, yielding levels of 
~-galactosidase activity greater than 1,000-fold over back- 
ground (Table I). 
To further investigate the interaction between the above 
PICKs and PKC, we tested whether they could interact with 
full-length PKCc~ or with amino acids 1-382 of PKC. This 
portion of the protein contains the regulatory domain, the 
hinge region, and ATP-binding domain, which lies between 
residues 346 and 368 (Coussens et al., 1986). Expression of 
both of these GALA fusion proteins in yeast was confirmed 
by Western blot analysis using anti-GALA antibody (data not 
shown). None of the PICKs were able to interact efficiently 
with full length PKCc~, suggesting that they interact with a 
region that is cryptic in the native enzyme, but which be- 
comes exposed when the enzyme is activated by deletion of 
the regulatory domain. Interestingly, PICK2. was able to in- 
teract with the regulatory domain of  PKC to an extent similar 
to its interaction with the catalytic domain (Table I). 
PICKs 1-5 Represent Novel Proteins 
To determine whether PICKs 1-5 might represent previously 
identified proteins, we sequenced the 5' and 3' ends of the 
cDNAs and searched the data base for amino acid or nucleo- 
tide homologies. No exact matches were found, indicating 
that these 5 cDNAs represent novel gene products. However, 
the deduced open reading frame of PICKI  from residues 
1%81 showed 53 % identity to that of an expressed sequence 
tag eDNA from Caenorhabditis elegans called cml9cl (Wa- 
terson et al.,  1992). This is the only region of this C.  ele- 
gans eDNA that has been sequenced. It will be interesting 
to determine whether the homology between these two gene 
products extends beyond their amino termini. 
We chose to focus further on the structure and function of 
PICK1  because it was the first PICK isolated and because, 
in contrast to the other cDNAs, Northern analysis suggested 
the PICK1 eDNA was near full-length. The 1771 bp PICK1 
eDNA was sequenced in its entirety and was found to contain 
a  long  uninterrupted  open  reading  frame in  frame  with 
GAL4 (1-147) (Fig. 2). Since the PICKI mRNA is ~ol,800 
nucleotides in length (see below), it is likely that this eDNA 
lacks a short amount of sequence at one or both ends. A me- 
thionine codon, preceded by a sequence in reasonable agree- 
ment with Kozak's consensus for translation initiation (Ko- 
zak,  1987),  was  located  12  residues  downstream  of the 
cloning junction  between  GALA  (1-147)  and  the  PICK1 
eDNA (Fig. 2). We believe this is the translation initiation 
site for PICK1 and that the additional residues between it and 
the cloning junction represent 5' untranslated sequences that 
are fortuitously in frame with both GAL4 and PICK1.  As- 
suming this to be the case, the PICK1 protein would contain 
416 amino acids  (Mr  =  46,522,  pI  =  5.21).  Evidence to 
support the conclusion that the first ATG in the eDNA can 
initiate translation comes from the observation that in vitro 
transcription  and  translation  of the  PICK1  eDNA  insert 
yields a polypeptide of Mr  =  55 kD (see Fig. 4). In addi- 
tion, the size of the PICK1 transcript suggests that all except 
100-200 nt are contained in the original PICK1 eDNA (see 
below). 
The PICK1 amino acid sequence contains several interest- 
ing motifs, including three potential PKC phosphorylation 
sites, R/KXXS/T, R/KXS/T (Pearson and Kemp, 1991). One 
of these is contained within a region that corresponds to a 
P-loop ATP/GTP binding motif (GXXXXGKS/T). This type 
of motif is contained in members of the RAS family of pro- 
teins,  as  well as guanylate kinase,  thymidine kinase,  and 
thymidylate kinase (Saraste et la.,  1990).  PICK1 does not 
contain any homology to the catalytic domains of known 
protein kinases. Near its carboxyl-terminus, PICK1 contains 
a stretch of acidic residues. 
PICK1 mRNA is Expressed in a Wide Range of 1issues 
Northern analysis of RNA from adult mouse tissues using 
the PICK1  eDNA as probe revealed a  major transcript of 
~1,800 nucleotides and a  minor transcript of ,,o 3,000 nt. 
PICK1  mRNA  was  present in  all  tissues  examined,  with 
The Journal of Cell Biology,  Volume 128, 1995  266 CTCGAGAT  TTACCGTCGGCCCCAAC  TCTCGGAACCATGTT  TGCAGACT  TAGAC  TATGACA  60 
M  F  A  D  L  D  Y  D  I  9 
TCGAAGAGGATAAATTAGGAATCCCCACTGTGCCTGGGAAGGTCACCCTACAGAAGGATG  120 
E  E  D  K  L  G  I  P  T  V  P  G  K  V  T  L  Q  K  D  A  29 
CCCAGAACCTGATTGGGATCAGCATCGGAGGAGGGGCCCAATACTGTCCTTGTCTC  TATA  180 
Q  N  L  I  S  I  S  I  G  S  G  A  Q  Y  C  P  C  L  X  I  49 
TCGTCCAGGTATT  TGATAACACGCCTGCAGCCTTGGATGGCACTGTGGCAGCTGGTGACG  240 
V  Q  V  F  D  N  T  P  A  A  L  D  G  T  V  A  A  G  D  E  69 
AGA  TCACTGGGGTCAATGGCAAG  TCAATCAAAG AAAAACCAAGGTAGAGGTGGCGAAGA  300 
I  T  S  V  N  [G  K  S  I  K  S  K  T_.  K  ]V  E  V  A  K  M  89 
TGATTCAGGAAGTGAAGGGGGAGGTGACCATCCAT TACAACAAGC  TGCAGGCGGACCCTA  360 
I  Q  E  V  K  G  E  V  T  I  H  Y  N  K  L  Q  A  D  P  K  109 
AGCAGGGCATG  TCCC  TGGACATTGTGTTGAAGAAAGTCAAGCACCGGCTGGTAGAAAACA  420 
Q  G  M  S  L  D  I  V  L  K  K  V  K  H  R  L  V  E  N  M  129 
TGAGTTCAGGCACAGCTGATGCCCTGGGCC TAAGCCGCGCCATCC  TGTGTAACGATGGCT  480 
S  S  G  T  A  D  A  L  G  L  S  R  A  I  L  C  N  D  G  L  149 
TGGTAAAGCGGC  TGGAGGAGC  TGGAACGCAC  TGCTGAGCTG  TACAAAGGGA  TGACGGAAC  540 
V  K  R  L  E  E  L  E  R  T  A  E  L  Y  K  G  M  T  E  H  169 
ACACCAAGAATCTCCTACGGGCCTT T  TATGACGTGTCGCAGACCCACCGGGCCTTTGGGG  600 
T  K  N  L  L  R  A  F  Y  D  V  S  Q  T  H  R  A  F  G  D  189 
ACGTGT  TC  TC  TGTGAT  TGGGGTGCGGGACGCGCAGCCAGCAGCAAGTGAAGCATT TGTGA  660 
V  F  S  V  I  G  V  R  D  A  Q  P  A  A  S  E  A  F  V  K  209 
AGT  TTGCAGACGCACACCGCAGCAT  TGAGAAGT  TCGGCAT  TCGGC  TACTGAAAACCATCA  720 
F  A  D  A  H  R  S  I  E  K  F  G  I  R  L  L  K  T_.  I  K  229 
AACCGA  TGCTGACGGACC  TGAACACGTACCTCAATAAAGCCATCCC  TGATACACGCCTCA  780 
P  M  L  T  D  L  N  T  Y  L  N  K  A  I  P  D  T  R  L  T  249 
CCATCAAGAAGTACCTGGATGTGAAGTTTGAGTACCTGTCGTACTGTCTAAAGGTGAAGG  840 
I  K  K  Y  L  D  V  K  F  E  Y  L  S  Y  C  L  K  V  K  E  269 
AGATGGATGACGAGGAATACAGC TGCAT  TGCCGCTAGGCGAGCCC  TATACCGAGTGAGCA  900 
M  D  D  E  E  Y  S  C  I  A  A  R  R  A  L  Y  R  V  S  T  289 
CAGGCAACTATGAGTACCGCCTCATTCTGCGCTGCCGCCAGGAGGCTCGAGCCCGCTTCT  960 
G  N  Y  E  Y  R  L  I  L  R  C  R  Q  E  A  R  A  R  F  S  309 
CCCAGATGCGCAAAGATGTTCTGGAGAAGATGGAGCTGCTGGA~CAGAAGCACGTCCAGG  1020 
Q  M  R  K  D  V  L  E  K  M  E  L  L  D  Q  K  H  V  Q  D  329 
ACATCGTGTTCCAGCTGCAGCGC TTCGTATCCACCATGTCCAAGTACTATAATGACTGCT  1080 
I  V  F  Q  L  Q  R  F  V  S  T  M  S  K  Y  Y  N  D  C  Y  349 
ATGCAGTGCTGCAGGACGCCGACGTCTTCCCCATTGAGGTGGACCTGGCACACACCACTC  i140 
A  V  L  Q  D  A  D  V  F  P  I  E  V  D  L  A  H  T  T  L  369 
TAGCC  TATGGCCC  TAACCAAGGCAGC  TTCAC  TGATGGAGAGGAGGAGGATGAAGAGGAGG  1200 
A  Y  G  P  N  Q  G  S  F  T  D  G  E  E  E  D  E  E  E  E  389 
AGGATGGGGCAGCTAGGGAAGTGTCCAAGGACGCATGTGGGGCCACTGGGCCTACGGACA  1260 
D  G  A  A  R  E  V  S  K  D  A  C  G  A  T  G  P  T  D  K  409 
AGGGCGGAAGC  TGGTGTGAC  TCC  TGAGTGCCCCCTCAAGT  GGACCTGGGGGGCAGGGTAG  1320 
G  G  S  W  C  D  S  416 
TGGGAGGACCGCAGTGGGAGTGGGGCGGGACCACTGTAGGACAGCGAAGGCATATAGTGG  1380 
CGCATAAAAGCCTC-CTGGCTCGGGGCGCCTGCCTCCCTGCTCCTCTGTCCTCAAACAGTG  I140 
AACCCAGGCTGCAGCCTGAGACCTGGACTCTAGCCCCCATCCATCCTTCCCATCTCCCAG  1500 
C  TAGAGGGAGAGC  TGGGC  TT  TGGACAGAAAAGAGAAGGGGC  TGGAGCAGACAGAGCACAG  1560 
GACCTGTCCCTGTGAGCGCCTCGGTGGTGCCAAGCCTGCAGGGAGTGGGAGCCGGGTGGA  1620 
CATCTGAGGCTGGGGCCAGTGTACCAGGGCAGCCCCTGAGTCCACATGCACACCTCAGCA  1680 
GCCTATATTTATTTGTTTCTGGTTTAGCCTCAAGGGCTGGAAGCTGGGCCTGTATTGAAT  1740 
AAACAGAAACCCAGGGTAAATCTCGAGCAGC  1771 
Figure  2.  Nucleotide  se- 
quence  and  predicted  open 
reading frame of PICK1.  The 
nueleotide sequence and pre- 
dicted open reading frame of 
the  PICK1  eDNA  is  shown. 
We  believe  that  the  first  33 
nueleotides  of  the  sequence 
represent  5tuntranslated  re- 
gion  that  is  fortuitously  in 
frame with GAL4(1-147)  and 
PICK1.  The methionine indi- 
cated as residue number 1 can 
serve as a translation initiation 
site in vitro. A  sequence that 
matches the P-loop motif is in- 
dicated  in  brackets  and  po- 
tential  PKC  phosphorylation 
sites are underlined. These se- 
quence data are available un- 
der  EMBL/GertBank/DDBJ 
accession number Z46720. 
highest levels in brain and testes and lowest levels in lung  glutathione agarose  beads,  revealed  that GST-PICK1  and 
(Fig.  3).  PKC7 could interact in vitro (Fig. 4 A). In contrast, PKC7 
showed no interaction with GST alone. 
To assess the specificity of the interaction between PICK1 
PICIO Interacts Specifically  with laCK In Vitro  and PKC7 and to determine whether it might represent an 
To further investigate the nature of the interaction between  enzyme-substrate  interaction,  we  tested  whether  [asS]me- 
PICK1  and activated PKC, we expressed PICK1  as a GST-  thionine-labeled PKC7 could interact with a GST-myogenin 
fusion  protein  and  tested  whether  it  could  interact  with  fusion protein, which is efficiently phosphorylated by PKC 
a  [32S]methionine-labeled  in  vitro  translation  product  of  (Li et al.,  1992); no interactions were detected (Fig. 4 A). 
PKC7.  Incubation  of  GST-PICK1  with  [35S]methionine-  As an additional negative control, we incubated GST-PICK1 
35  labeled PKC7, followed by recovery of the fusion protein on  with  [  S]methionine-labeled MEF2C,  a  transcription fac- 
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PICK1 mRNA in adult mouse 
tissues.  A 32p-labeled PICK1 
cDNA probe was hybridized 
to  poly(A)+mRNA from the 
indicated  mouse  tissues.  A 
major  species  of  ~1,800  nt 
and  a  minor  species  of 
'~ 3,000 nt are observed in all 
tissues. 
tor containing several potential PKC phosphorylation sites, 
and detected no interaction (Fig. 4 A). These results confirm 
that  the  catalytic  domain  of PKC  interacts  directly  with 
PICKI  and  rule  out  the  possibility  that  the  activation of 
marker gene expression in yeast by the two proteins together 
is due to an indirect mechanism or to the involvement of an 
intermediary protein. 
We also investigated whether GST-PICK1 could interact 
with full length PKCcx in vitro. In the absence of cofactors, 
PKCot  interacted  weakly  with  GST-PICK1 and  there  was 
about a twofold increase in binding of PKCo~ to GST-PICK1 
in the presence of cofactors for PKC activation (Fig. 4, B and 
C).  In the presence of PKC activators,  PKCo~ bound less 
efficiently to GST-PICK1 than did PKC7 (Fig. 4 B and C), 
suggesting that the PICKl-binding site in PKCo~ was not fully 
exposed upon catalytic activation or that a portion of in vitro 
translated PKCc¢ was not activatable. 
PICKI Is a Substrate for PKC In Vitro 
We next examined whether PICK1 might be a substrate for 
PKC by incubating GST-PICK1 in the presence of purified 
PKCcx,  essential  cofactors,  and  7-P2p]ATP,  followed  by 
analysis of the reactions by SDS-PAGE. As shown in Fig. 5, 
the 72-kD GST-PICK1 fusion protein was efficiently phos- 
phorylated by PKC in vitro. Because GST alone is not a sub- 
strate for PKC (Li et al.,  1992), we conclude that 32p is in- 
corporated into the PICK1 portion of the fusion protein. 
PICKI Is Phosphorylated Following PKC Activation 
In Vivo 
To test whether PICK1 can be phosphorylated in response to 
PKC activation in vivo, we transfected COS cells with an 
epitope-tagged  PICKI  expression  vector.  24  h  following 
transfection,  cells  were  labeled  with  [32p]orthophosphate 
for 8 h, after which they were exposed to PDBu for 30 rain. 
Extracts were then prepared and PICK1 was immunoprecipi- 
tated using an antibody directed against the epitope tag. In 
the absence of PDBu,  the 55-kD PICK1 protein showed a 
low, but detectable level of labeling with 32p (Fig. 6),  indi- 
caring that it exists in vivo as a phosphoprotein. In the pres- 
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Figure 4. Interaction between PICK1 and PKC7 in vitro, cDNAs for PICKI, PKCcx, PKC7, and MEF2C were transcribed  and translated 
in vitro and [35S]methionine-labeled in vitro translation products were analyzed by SDS-PAGE followed by autoradiography  (A, left four 
lanes; B, lanes 1 and 2). Unprogrammed lysate is shown in A, far left lane. The in vitro translation products were incubated with GST-PICK1, 
GST-myogenin (GST-myo), or GST alone, as indicated. In B, incubations with PKCa were performed in the presence (lanes 3 and 4) or 
absence (lanes 5 and 6) of cofactors for PKCa and in the absence of cofactors for PKC7 (lanes 7 and 8). After recovery of the fusion 
proteins by binding to glutathione agarose beads, the reactions were analyzed by SDS-PAGE. Four times as much of the in vitro products 
were contained  in the binding reactions as were applied to the lanes for total products.  In C, the amount of in vitro product bound to 
GST-PICK1 was quantitated by excising the corresponding region of the gel and counting in a scintillation counter. The [32S]methionine- 
labeled PKC7 and PKCc~ translation products bound specifically to GST-PICK1. Molecular weight markers are indicated at the left in A. 
Similar results were obtained in three separate sets of experiments. 
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GST-PICK1 by PKC in vitro. 
1  ~tg  of  GST-PICK1  fusion 
protein was incubated in vitro 
with purified PKCa, eofaetors 
and 3,-[32p]ATP as described 
in Materials and Methods. At 
the end of the reaction,  pro- 
teins were separated by SDS- 
PAGE followed by autorading- 
raphy. The species migrating 
at 30 kD is GST, which arises 
from proteolysis. The lack of 
phosphorylation of  GST alone 
can  be  seen  by  comparing 
the  autoradiograph  with  the 
stained  gel.  Molecular  mass 
markers are indicated at the fight. There is substantial proteolysis 
of  the bacterial fusion protein near the junction of (;ST and PICKI, 
which yields GST migrating at 30 kD, but there is no detectable 
phosphorylation of  this species. We believe that the labeled species 
migrating near the top of the gel is insoluble material trapped in 
the well of the gel. 
ence  of PDBu,  multiple  phosphorylated  forms of PICK1 
were  observed.  These  results  demonstrate  that  PICK1  is 
phosphorylated in vivo as a consequence of PKC activation. 
Given that PKC phosphorylates PICK1 in vitro, it is likely 
that the enhanced phosphorylation in response to PKC acti- 
vation in vivo also reflects direct phosphorylation by PKC. 
In some experiments,  such as the  one shown in Fig.  6, 
PICK1  migrated  as  a  heterogeneous  series  of  bands  of 
'~45-55  kD.  Because  the  same bands  are  observed with 
[35S]methionine  labeling  in  the  presence  and  absence  of 
PDBu,  we  do not  believe they arise as a  consequence  of 
phosphorylation. It is more likely that PICK1 is sensitive to 
proteolysis in vivo. 
PICK1 Is Localized to the Perinuclear Region 
Using the epitope-tagged PICK1 expression vector, we also 
examined the subcellular distribution of PICKI by immuno- 
staining transiently transfected COS cells. Cells transfected 
Figure 6.  Phosphorylation  of 
PICK1 in response to PKC ac- 
tivation  in  vivo.  COS1 cells 
were  transiently  transfected 
with the PECE FLAG expres- 
sion vector encoding epitope- 
tagged  PICK1 or  lacking  a 
eDNA  insert  (mock).  Cul- 
tures  were  labeled  with  32p 
and  exposed  to  PDBu  (500 
/zg/ml) for 30 min before har- 
vesting. PICK1 was immuno- 
precipitated from cell extracts 
using anti-FLAG antibody, as described in Materials and Methods. 
Multiple  PICK1 species,  designated  by arrowheads,  were phos- 
phorylated in response to PDBu. Molecular weight markers are in- 
dicated at the left. 
with the  PICK1  expression vector showed intense perinu- 
clear  staining,  as  well  as  a  low  level of diffuse  staining 
throughout  the  cytoplasm (Fig.  7).  In many cells,  PICK1 
staining appeared to be concentrated to one side of the nu- 
cleus, perhaps to the rough endoplasmic reticulum or Golgi. 
Using a nonspecitic antibody or nonimmune serum, no stain- 
ing was observed (data not shown). 
Discussion 
We have cloned five novel proteins that interact with PKC, 
using the  yeast two-hybrid system,  These proteins,  called 
PICKs, interact with the catalytic domain of PKC, but not 
with the full-length enzyme when expressed in yeast. Activa- 
tion of PKC following the binding of cofactors to the regula- 
tory domain is accompanied by a conformational change in 
which  the  amino-terminal  pseudosubstrate  sequence  is 
released from the active site (House and Kemp, 1987).  The 
failure of our cloned PICKs to interact efficiently with full- 
length PKC suggests that they recognize determinants that 
are masked in the inactive enzyme, but which may become 
exposed when the enzyme becomes activated. 
We  have  focused  in  this  study  on  PICK1,  which  is  a 
Figure 7. Immunoloealization of PICKI in transfected COS cells. COS cells were transiently transfected with the PECE FLAG-PICK1 
expression vector. Two days after transfection, cells were stained with a monoclonal antibody specific for the FLAG epitope. Three repre- 
sentative transfected cells are shown. FLAG-PICKl-expressing  cells showed intense staining in the perinuclear region and diffuse staining 
in the cytoplasm.  No staining was observed in cells transfected with the PECE FLAG expression vector lacking a eDNA insert. 
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vivo and in vitro. PICK1 binds tightly to the PKC deletion 
mutant PKC7, which encompasses amino acids 302-672 of 
PKCct, but it does not interact with a PKC deletion mutant 
encompassing amino acids 1-382.  Thus, it is likely that the 
binding site for PICK1 lies between residues 383 and 672 of 
PKC. This portion of PKC contains the active site,  in con- 
served region 4, and variable regions 4 and 5. PICK1 con- 
tains a potential ATP/GTP binding motif, but it remains to 
be determined whether this is important for its function. 
The properties of PICK1  suggest it may play a dual role 
in mediating the actions of PKC, by binding the enzyme and 
by serving as a substrate for phosphorylation. The binding 
site for PICK1  lies within the region of PKC that contains 
the active site. We believe, however, that PKC binding and 
phosphorylation of PICK1 may be independent activities be- 
cause PKC7 failed to interact in vitro with a myogenin fusion 
protein,  a  known  substrate  for  PKC  (Li  et  al.,  1992). 
GAL4(DB)-PKC7 also fails to interact with MyoD in the 
yeast two-hybrid system (Staudinger  et  ai.,  1993),  even 
though MyoD is an excellent substrate for the enzyme (Li et 
al.,  1992).  Similarly, we have been unable to detect inter- 
actions in yeast between GAL4(DB)-PKC7 and MARCKS 
(Blackshear,  1993),  a well defined PKC substrate (J. Stau- 
dinger, unpublished observations). These results suggest that 
interactions between PKC and its substrates may alone be in- 
sufficiently stable to detect using the two-hybrid system. 
Numerous PKC isoforms have been shown to translocate 
to the perinuclear region (Chen et al.,  1987; Halsey et al., 
1987;  Thomas et al.,  1988;  Fields et al.,  1989;  Mochly- 
Rosen et al., 1990; James and Olson, 1992). In fact, the sub- 
cellular distribution of PICK1 is remarkably similar to that 
of activated PKCot in COS cells (James and Olson,  1992). 
Whether PICK1  may play a role in localizing PKC to the 
perinuclear region or whether it simply interacts with PKC 
once it has been translocated there remains to be  deter'- 
mined. Because different isoforms of PKC are translocated 
to different subcellular sites, it will be interesting to deter- 
mine whether PICK1 shows a preference for interaction with 
certain PKC isoforms. 
Previously we showed that PKC7  was localized specifi- 
cally to the nuclei of transfected COS cells (James and O1- 
son, 1992), a result confirmed by others (Eldar et al., 1992). 
This specific localization suggests the existence of a cryptic 
nuclear localization signal in PKCct that is exposed upon de- 
letion of the regulatory domain (James and Olson,  1992). 
The subcellular distribution of PICK1 suggests that it is not 
an intranuclear receptor for PKC7.  Whether other PICKs 
may play a role in localizing PKC to the nucleus remains to 
be determined. 
The existence of intracellular PKC binding proteins, or 
RACKS, has been demonstrated in previous studies by bind- 
ing assays of PKC to proteins in cell extracts (Mochly-Rosen 
et al., 1990, 1991a, b). Binding of RACKs to PKC is depen- 
dent on the presence of PS, diacylglycerol, and calcium, 
which are likely to result in exposure of  the otherwise cryptic 
RACK-binding site in PKC. The binding site for RACKS on 
PKC appears to lie NH2-terminal  to the catalytic domain 
and is unaffected by enzyme-substrate interactions. 
Ron et al. (1994) recently cloned a PKC-binding protein, 
called RACK1, using a PKC overlay assay. Sequence analysis 
showed RACK1 to be a homologue of the B subunit of G-pro- 
teins. Binding of PKC to RACK1 is dependent on the pres- 
ence of PKC activators and could be competed by synthetic 
peptides homologous to PKC-binding sequences in annexin 
I and the brain PKC inhibitor KCIP. Peptides derived from 
the pseudosubstrate sequence had no effect on binding, indi- 
cating that binding did not reflect enzyme-substrate interac- 
tions. 
Chapline et al. (1993) have also isolated two PKC-binding 
proteins;  one was the MARCKS-related protein F52,  the 
other appeared to be novel, but showed homology to the 
carboxyl-terminus of/3-adducin. Both proteins were sub- 
strates for PKC and bound PS, which was suggested to be 
an important component of PKC binding. Following phos- 
phorylation by PKC, these types of PKC-binding proteins 
were no longer able to bind the enzyme (Chapline et al., 
1993;  Hyatt et al.,  1994).  Regions of high positive charge 
density in MARCKS and the/~-adducin homologue were 
suggested to mediate their binding to PKC (Chapline et al., 
1993).  PICK1 contains no such region, nor does it contain 
homology to the PKC-binding motifs in annexin I and KCIP. 
It  also  appears  that  PKC  binds  equally  well  to  phos- 
phorylated and unphosphorylated PICK1 (J. Staudinger and 
E. Olson, unpublished results). This suggests the existence 
of multiple classes of PKC binding proteins with different 
functions in the PKC signal transduction pathway. 
Several  protein  kinases  in  addition to  PKC  have been 
shown to bind intracellular receptors. For example, localiza- 
tion of protein kinase A to specific subcellular sites has been 
shown to be dependent on its association with A kinase-an- 
choring proteins  (Carr  et al.,  1992).  pt0  ~rc also binds  a 
specific receptor on the cytoplasmic surface of the plasma 
membrane (Resh,  1994) and Raf-1 kinase associates spe- 
cifically with the cytoplasmic domain of the PDGF receptor 
(Morrison et al.,  1989).  Further analysis of PICK1  and of 
PICKs 2-5 should yield additional insight into the functions 
of intracellular protein kinase-binding proteins in general 
and of the specific mechanisms whereby PKC regulates cell 
proliferation, differentiation, and oncogenesis. 
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